[{"Assets_0_FY_USD":1070206000.0,"CommonStockSharesOutstanding_0_FY_shares":49405365.0,"EarningsPerShareBasic_4_FY_USD":1.98,"EarningsPerShareDiluted_4_FY_USD":1.71,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":208139000.0,"NetIncomeLoss_4_FY_USD":82594000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":50327937.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":41816431.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180223"}]